Principal Financial Group’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$28.7M Sell
796,674
-44,337
-5% -$1.6M 0.02% 660
2025
Q1
$33.2M Buy
841,011
+10,827
+1% +$427K 0.02% 571
2024
Q4
$25M Buy
830,184
+57,996
+8% +$1.75M 0.01% 729
2024
Q3
$18.1M Buy
772,188
+725,371
+1,549% +$17M 0.01% 905
2024
Q2
$833K Buy
46,817
+11,443
+32% +$204K ﹤0.01% 1877
2024
Q1
$538K Buy
35,374
+1,322
+4% +$20.1K ﹤0.01% 1971
2023
Q4
$582K Buy
34,052
+412
+1% +$7.04K ﹤0.01% 1932
2023
Q3
$281K Sell
33,640
-18,439
-35% -$154K ﹤0.01% 2074
2023
Q2
$1.29M Sell
52,079
-11,897
-19% -$296K ﹤0.01% 1812
2023
Q1
$962K Buy
63,976
+24,346
+61% +$366K ﹤0.01% 1858
2022
Q4
$469K Buy
39,630
+3,722
+10% +$44K ﹤0.01% 1993
2022
Q3
$213K Sell
35,908
-785
-2% -$4.66K ﹤0.01% 2189
2022
Q2
$156K Sell
36,693
-3,204
-8% -$13.6K ﹤0.01% 2336
2022
Q1
$380K Buy
39,897
+776
+2% +$7.39K ﹤0.01% 2180
2021
Q4
$743K Sell
39,121
-16,163
-29% -$307K ﹤0.01% 2042
2021
Q3
$1.84M Buy
55,284
+1,860
+3% +$61.9K ﹤0.01% 1885
2021
Q2
$2.07M Buy
53,424
+877
+2% +$34K ﹤0.01% 1898
2021
Q1
$2.53M Buy
52,547
+395
+0.8% +$19K ﹤0.01% 1817
2020
Q4
$2.71M Buy
52,152
+15,830
+44% +$823K ﹤0.01% 1738
2020
Q3
$972K Sell
36,322
-709
-2% -$19K ﹤0.01% 1876
2020
Q2
$722K Buy
37,031
+11,840
+47% +$231K ﹤0.01% 1888
2020
Q1
$247K Buy
25,191
+790
+3% +$7.75K ﹤0.01% 2013
2019
Q4
$271K Buy
24,401
+12,760
+110% +$142K ﹤0.01% 2074
2019
Q3
$65K Buy
+11,641
New +$65K ﹤0.01% 2203
2018
Q4
Sell
-11,063
Closed -$62K 2306
2018
Q3
$62K Buy
+11,063
New +$62K ﹤0.01% 2257